ERICA (SEIGUER) SHENOY is the Medical Director of Infection Control at Mass General Birmingham, the Associate Chief of the Infection Control Unite at Massachusetts General Hospital, and an Associate Professor at Harvard Medical School.
Erica was born in Baltimore to parents from Argentina.
Erica graduated from Princeton University with a degree in molecular biology and a certificate from the Woodrow Wilson School of Public and International Affairs. She received her MD from Harvard Medical School in 2007, and a Ph.D. from Harvard University in Health Policy/Economics in the same year.
Erica completed her residency training in internal medicine at the Massachusetts General Hospital (MGH) and fellowship in Infectious Diseases at MGH.
Erica is an infectious diseases physician at Massachusetts General Hospital (MGH) where she is Associate Chief of the Infection Control Unit. She is an Associate Professor of Medicine at Harvard Medical School and is trained as a health economist. Her research has evaluated the clinical, operational and economic impact of competing infection control strategies for multi-drug resistant pathogens and hospital acquired infections through clinical studies and mathematical modeling, has leveraged electronic health records for infection control surveillance, and applied machine-learning techniques to create risk prediction models for communicable diseases. She has investigated and published on detection and prevention of nosocomial infections, and has collaborated on research and implementation of interventions to improve antibiotic use in patients with history of antibiotic allergies.
Erica is Medical Director of the Regional Emerging Special Pathogens Treatment Center at MGH, one of 10 facilities supported by the US Department of Health and Human Services as part of the regional treatment network for emerging pathogens, and is a Fellow in both the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). She has served on the Guidelines Committee of SHEA and currently a member of SHEA’s Public Policy and Government Affairs Committee and co-chair of the Sterilization and High-Level Disinfection guidelines committee. An active member of IDSA, she previously served on the IDSA Antimicrobial Resistance Committee.
